A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis

EBioMedicine

Volumn 10, Issue , 2016, Pages 227-235

  Olsen, John A ^a   Kenna, Lauren A ^a   Tipon, Regine C ^a   Spelios, Michael G ^a   Stecker, Mark M ^a   Akirav, Eitan M ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Biomarker discovery; Circulating free DNA; Cuprizone; Human patients; Oligodendrocyte; Relapsing remitting multiple sclerosis

Indexed keywords

BISULFITE; CUPRIZONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL LOSS; CONTROLLED STUDY; DEMYELINATION; DNA METHYLATION; DNA PURIFICATION; ENZYME KINETICS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SEQUENCE; HUMAN; MINIMALLY INVASIVE PROCEDURE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROCYTE PROGENITOR; OLIGODENDROGLIA; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ADULT; ANIMAL; BLOOD; CELL LINE; CENTRAL NERVOUS SYSTEM; GENETICS; METABOLISM; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; SCHWANN CELL;

ADULT; ANIMALS; BIOMARKERS; CELL LINE; CENTRAL NERVOUS SYSTEM; DNA METHYLATION; FEMALE; HUMANS; MICE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OLIGODENDROGLIA; SCHWANN CELLS;

EID: 85027947285     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.06.031     Document Type: Article

References (28)

1. Adelman, G., Rane, S.G., Villa, K.F., The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J. Med. Econ. 16:5 (2013), 639–647.
2. Akirav, E.M., Lebastchi, J., Galvan, E.M., et al. Detection of beta cell death in diabetes using differentially methylated circulating DNA. Proc. Natl. Acad. Sci. U. S. A. 108:47 (2011), 19018–19023.
3. Bunge, R.P., Glial cells and the central myelin sheath. Physiol. Rev. 48:1 (1968), 197–251.
4. Bunge, M.B., Bunge, R.P., Pappas, G.D., Electron microscopic demonstration of connections between glia and myelin sheaths in the developing mammalian central nervous system. J. Cell Biol. 12 (1962), 448–453.
5. Chen, X.Q., Stroun, M., Magnenat, J.L., et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2:9 (1996), 1033–1035.
6. Coffey, J.C., McDermott, K.W., The regional distribution of myelin oligodendrocyte glycoprotein (MOG) in the developing rat CNS: an in vivo immunohistochemical study. J. Neurocytol. 26:3 (1997), 149–161.
7. Crowley, E., Di Nicolantonio, F., Loupakis, F., Bardelli, A., Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10:8 (2013), 472–484.
8. Felts, P.A., Baker, T.A., Smith, K.J., Conduction in segmentally demyelinated mammalian central axons. J. Neurosci. 17:19 (1997), 7267–7277.
9. Ferguson, B., Matyszak, M.K., Esiri, M.M., Perry, V.H., Axonal damage in acute multiple sclerosis lesions. Brain J. Neurol. 120:Pt 3 (1997), 393–399.
10. Fitzner, B., Hecker, M., Zettl, U.K., Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients. Autoimmun. Rev. 14:10 (2015), 903–913.
11. Gardinier, M.V., Amiguet, P., Linington, C., Matthieu, J.M., Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33:1 (1992), 177–187.
12. Johns, T.G., Bernard, C.C., The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72:1 (1999), 1–9.
13. Jones, P.A., Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13:7 (2012), 484–492.
14. Kobelt, G., Berg, J., Lindgren, P., Fredrikson, S., Jonsson, B., Costs and quality of life of patients with multiple sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry 77:8 (2006), 918–926.
15. Lebar, R., Lubetzki, C., Vincent, C., Lombrail, P., Boutry, J.M., The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66:2 (1986), 423–434.
16. Lehmann-Werman, R., Neiman, D., Zemmour, H., et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl. Acad. Sci. U. S. A. 113:13 (2016), E1826–E1834.
17. Li, L.C., Dahiya, R., MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:11 (2002), 1427–1431.
18. Lindner, M., Heine, S., Haastert, K., et al. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 34:1 (2008), 105–114.
19. Linnington, C., Webb, M., Woodhams, P.L., A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:6 (1984), 387–396.
20. Nawroz, H., Koch, W., Anker, P., Stroun, M., Sidransky, D., Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2:9 (1996), 1035–1037.
21. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., Weinshenker, B.G., Multiple sclerosis. N. Engl. J. Med. 343:13 (2000), 938–952.
22. Olsen, J.A., Akirav, E.M., Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. J. Neurosci. Res. 93:5 (2015), 687–696.
23. Olsen, J.A., Kenna, L.A., Spelios, M.G., Hessner, M.J., Akirav, E.M., Circulating differentially methylated amylin DNA as a biomarker of beta-cell loss in type 1 diabetes. PLoS One, 11(4), 2016, e0152662.
24. Polman, C.H., Reingold, S.C., Banwell, B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69:2 (2011), 292–302.
25. Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., Ponsaerts, P., Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci. Biobehav. Rev. 47 (2014), 485–505.
26. Solly, S.K., Thomas, J.L., Monge, M., et al. Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 18:1 (1996), 39–48.
27. Teunissen, C.E., Malekzadeh, A., Leurs, C., Bridel, C., Killestein, J., Body fluid biomarkers for multiple sclerosis-the long road to clinical application. Nat. Rev. Neurol. 11:10 (2015), 585–596.
28. Waxman, S.G., Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch. Neurol. 34:10 (1977), 585–589.